FDA Compliance for Peptide Therapy and BPC 157 Holt Law Analysis: The peptide problem: Hype is outrunning the evidence McMaster News RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Ligament: 1 Unsafe Truth